Drug intelligence / Profile preview

sodium chloride + calcium chloride + magnesium chloride + dextrose monohydrate + sodium

Development stage
Approved
Lead developer
Takeda
Modality
Small Molecules
Administration
Intraperitoneal
01

Overview

This entry refers to a **multi-electrolyte peritoneal dialysis solution** composed of sodium chloride, calcium chloride, magnesium chloride, dextrose monohydrate, and an additional sodium-containing buffer component, most plausibly **sodium lactate** based on approved U.S. product labels for closely matching formulations such as DIANEAL. These solutions are pharmacologically inactive replacement/dialysis fluids rather than receptor-targeted drugs: dextrose creates an osmotic gradient across the peritoneal membrane to drive ultrafiltration, while the electrolyte and buffer components help correct fluid, electrolyte, and acid-base abnormalities during peritoneal dialysis. The formulation class is used for the management of **acute renal failure**, **chronic renal failure**, and **chronic kidney failure** via **intraperitoneal** administration. Because the input name omits the exact sodium salt/buffer and does not uniquely map to a single branded product, it is best treated as a nonspecific formulation-level description rather than one uniquely identifiable commercial drug.

Other names
sodium chloride + calcium chloride + magnesium chloride + dextrose monohydrate + sodiumsodium chloride + sodium lactate + calcium chloride + magnesium chloride + dextroseperitoneal dialysis solution with dextrose

Beyond the preview

Go deeper on sodium chloride + calcium chloride + magnesium chloride + dextrose monohydrate + sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium chloride + calcium chloride + magnesium chloride + dextrose monohydrate + sodium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call